In sum, IL-6/IL-10 mRNA expression ratio was identified as an independent prognostic factor for GC patients without distant metastasis for the first time, which provided a novel and powerful tool for a more rational management of GC patients. The gene discussed is IL10; the disease is gastric cancer.